2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Cited by (1,000)

Items 501–600 of 1,000

1. Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study
   Carlos Esteban Builes-Montaño, Luis Antonio Rodriguez Arrieta, Alejandro Román-Gonzaléz, Carolina Prieto, José C Álvarez-Payares, Carlos Alfonso Builes Barrera, Clara María Arango Toro · 2021 · Journal of Clinical Apheresis
2. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves’ Disease: A Nationwide Population-Based Cohort Study
   Eyun Song, Mina Kim, Sojeong Park, Minjeong Park, Jung A Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Ji A Seo, Sin Gon Kim et al. · 2021 · Frontiers in Endocrinology
3. Non-Conventional Clinical Uses of TSH Receptor Antibodies: The Case of Chronic Autoimmune Thyroiditis
   Giorgio Napolitano, Ines Bucci, Giulia Di Dalmazi, Cesidio Giuliani · 2021 · Frontiers in Endocrinology
4. Subclinical male hypogonadism
   Giovanni Corona, Giulia Rastrelli, Mauro Dicuio, Sergio Concetti, Marianna Minnetti, Rosario Pivonello, Andrea Maria Isidori, Alessandra Sforza, Mario Maggi · 2021 · Minerva Endocrinology
5. Diosgenin From Dioscorea Nipponica Rhizoma Against Graves’ Disease—On Network Pharmacology and Experimental Evaluation
   Jingxin Xin, Wencong Cheng, Yongbing Yu, Juan Chen, Xinhuan Zhang, Shanshan Shao · 2022 · Frontiers in Pharmacology
6. Controversies in the pharmacological treatment of Graves’ disease in children
   Filippo De Luca, Mariella Valenzise · 2018 · Expert Review of Clinical Pharmacology
7. Increased Risk of Antithyroid Drug Agranulocytosis Associated with Amiodarone-Induced Thyrotoxicosis: A Population-Based Cohort Study
   Michal Gershinsky, Walid Saliba, Idit Lavi, Chen Shapira, Naomi Gronich · 2019 · Thyroid
8. Two-year outcomes of single-session high-intensity focused ultrasound (HIFU) treatment in persistent or relapsed Graves’ disease
   Brian Hung‐Hin Lang, Yu Cho Woo, Keith Wan-Hang Chiu · 2019 · European Radiology
9. Assessment and Management of Thyroid Disease in Children
   Amy L. Dimachkieh, Ken Kazahaya, Daniel C. Chelius · 2019 · Otolaryngologic Clinics of North America
10. High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves’ Disease
    Wei Lin Tay, Chiaw Ling Chng, Carolyn SY Tien, Kelvin Loke, Winnie Wing-Chuen Lam, Stephanie Man Chung Fook-Chong, Aaron Kian Ti Tong · 2019 · Annals of the Academy of Medicine Singapore
11. Infiltration of the thyroid gland by non-thyroid malignancy: A literature review reveals this to be an unusual cause of hyperthyroidism
    Jacqueline Jonklaas · 2020 · Journal of Clinical & Translational Endocrinology
12. Short-Term Outcomes of Surgery for Graves’ Disease in Germany
    Elisabeth Maurer, Christian Vorländer, A. Zielke, Cornelia Dotzenrath, Moritz von Frankenberg, Hinrich Köhler, Kerstin Lorenz, Theresia Weber, Joachim Jähne, Antonia Hammer et al. · 2020 · Journal of Clinical Medicine
13. Long-term antithyroid drug therapy
    David S. Cooper · 2021 · Current Opinion in Endocrinology Diabetes and Obesity
14. Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
    Helena Kerp, Georg Sebastian Hönes, Elen Tolstik, Judith Hönes-Wendland, Janina Gassen, Lars Christian Moeller, Kristina Lorenz, Dagmar Führer · 2021 · Frontiers in Cardiovascular Medicine
15. Two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination
    Hayri Bostan, İlknur Öztürk Ünsal, Muhammed Kızılgül, Umran Gul, Muhammed Erkam Sencar, Bekir Uçan, Erman Çakal · 2022 · Archives of Endocrinology and Metabolism
16. Predictors of Hypothyroidism Following Empirical Dose Radioiodine in Toxic Thyroid Nodules: Real-Life Experience
    Busra Kuyumcu Demir, Ersen Karakılıç, Emre Sedar Saygılı, Nilgün Aracı, Semra Özdemir · 2022 · Endocrine Practice
17. Successful Management of Recurrent Subacute Thyroiditis by Adding Colchicine to Glucocorticoid Treatment: A Case Series Study
    Zhenhua Tian, Yu‐Xiong Su, Mei‐Jie Zhang, Xiujuan Zhang, Qingbo Guan · 2020 · Hormone and Metabolic Research
18. Update on Pediatric Hyperthyroidism
    Priya Vaidyanathan · 2022 · Advances in Pediatrics
19. Therapeutic plasma exchange in hyperthyroidism prior to surgery
    Hakkı Onur Kırkızlar, Mehmet Çelik · 2022 · Journal of Endocrinological Investigation
20. Four cases of Graves’ disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine
    Shakun Chaudhary, Vinay Dogra, Rama Walia · 2022 · Endocrine Journal
21. Real-life Data on the Effect of Medical Therapy for Amiodarone-induced Thyrotoxicosis on CV Events and Hospitalizations
    Daniele Cappellani, Giulia Marconcini, Luca Manetti, Luigi Bartalena, Fausto Bogazzi · 2022 · The Journal of Clinical Endocrinology & Metabolism
22. Immunotherapy-induced thyroid dysfunction: an updated review
    Bahaaeldin Baraka, Hazem Maarouf Abosheaishaa, Mahmoud Nassar · 2023 · The Egyptian Journal of Internal Medicine
23. Iodine-induced thyroid dysfunction: a scientometric study and visualization analysis
    Boshen Gong, Xichang Wang, Chuyuan Wang, Wanyu Yang, Zhongyan Shan, Yaxin Lai · 2023 · Frontiers in Endocrinology
24. Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpoint
    Pierpaolo Trimboli, Joerg Bojunga, Maurilio Deandrea, Francesco Frasca, Alessio Impériale, Andrea Leoncini, Gaetano Paone, Fabián Pitoia, Mario Rotondi, Ramin Sadeghi et al. · 2024 · Endocrine
25. The Two-Year Results of Using Radiofrequency Ablation as a Novel Treatment for Persistent or Relapsed Graves’ Disease: A Prospective Study
    Matrix Man Him Fung, Yan Luk, Karen Ka-Wan Yuen, Brian Hung‐Hin Lang · 2024 · Thyroid
26. Thyroid Disorders in Athletes
    John R. Luksch, Philip B. Collins · 2018 · Current Sports Medicine Reports
27. Thyrotoxic heart failure: A review of clinical status and meta-analysis of electrocardiogram diagnosis and medical clinical management methods
    Aref Albakri · 2018 · Integrative Molecular Medicine
28. Association of Radioactive Iodine Treatment of Hyperthyroidism With Cancer Mortality: An Unjustified Warning?
    Elif Hindié, Kenneth B. Ain, Slimane Zerdoud, Anca M. Avram · 2019 · The Journal of Clinical Endocrinology & Metabolism
29. Predictors of euthyreosis in hyperthyroid patients treated with radioiodine 131I−: a retrospective study
    A. Stachura, Tomasz Gryn, Bernadetta Kałuża, T. Budlewski, E. Franek · 2020 · BMC Endocrine Disorders
30. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves’ hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves’ hyperthyroidism
    Sayid Shafi Zuhur, Ogün Bilen, Hünkar Ağgül, Birol Topçu, Aliye Çelikkol, Gülşah Elbüken · 2020 · Endokrynologia Polska
31. Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States
    Yao Wang, Anu Rani Sharma, Lissa Padnick‐Silver · 2020 · Journal of the Endocrine Society
32. Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia
    Francesco Saettini, Alessandro Cattoni, Martina Baiardo Redaelli, Daniela Silvestri, Giulia Maria Ferrari, Andrea Biondi, Momcilo Jankovic, Marco Spinelli · 2020 · Acta Paediatrica
33. Successful intervention with Chinese herbal medicine for hyperthyroidism: Two case reports and a literature review
    Chia-Hui Lin, Chun-Pang Lin, Sheng‐Teng Huang · 2020 · EXPLORE
34. Total versus near-total thyroidectomy in Graves’ disease: a systematic review and meta-analysis of comparative studies
    Lan Mu, Chutong Ren, Jiangyue Xu, Can Guo, Jiangsheng Huang, Ke Ding · 2021 · Gland Surgery
35. Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves’ disease
    Xinxin Chen, Yanqiu Wang, Yicheng Qi · 2021 · Scientific Reports
36. Influence of SARS-CoV-2 infection on thyroid gland function: The current knowledge
    Małgorzata Zgorzalewicz-Stachowiak, Agata Czarnywojtek, Alicja Ochmańska, Nadia Sawicka‐Gutaj, Beata Matyjaszek‐Matuszek, Magdalena Woźniak, Marek Ruchała · 2021 · Advances in Clinical and Experimental Medicine
37. Graves’ disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study
    Yoon Young Cho, Bongseong Kim, Dughyun Choi, Chul‐Hee Kim, Dong Wook Shin, Jee Soo Kim, Seung‐Jung Park, Sun Wook Kim, Jae Hoon Chung, Kyungdo Han et al. · 2022 · Frontiers in Endocrinology
38. Significance of HLA in the development of Graves’ orbitopathy
    Magdalena Stasiak, Katarzyna Zawadzka-Starczewska, Bogusław Tymoniuk · 2023 · Genes and Immunity
39. Serum Lipidomic Analysis Reveals Biomarkers and Metabolic Pathways of Thyroid Dysfunction
    Hua Dong, Wenjie Zhou, Xingxu Yan, Huan Zhao, Honggang Zhao, Yan Jiao, Guijiang Sun, Yubo Li, Zuncheng Zhang · 2023 · ACS Omega
40. New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases
    Kan Chen, Yiyang Gao, Jing Li · 2023 · European journal of medical research
41. Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
    Jaafar Jaafar, Eugenio Fernández, Heba Alwan, Jacques Philippé · 2018 · Endocrine Connections
42. A review of the propriety of thyroid ultrasound referrals and their follow-up burden
    Colin Davenport, Jack Alderson, Ivan G. Yu et al. · 2019 · Endocrine
43. Variation in the Quality of Thyroid Nodule Evaluations Before Surgical Referral
    Lan Jiang, Cortney Y. Lee, DAVID A. SLOAN, Reese W. Randle · 2019 · Journal of Surgical Research
44. Transient Hyperthyroidism following the ingestion of complementary medications containing kelp seaweed
    Adriana Gherbon, Mirela Frandeș, Diana Lungeanu · 2019 · Medicine
45. Improving laboratory test utilisation at the multihospital Yale New Haven Health System
    Roa Harb, David Hajdasz, Marie Louise Landry, L. Scott Sussman · 2019 · BMJ Open Quality
46. Current controversies in the management of Graves’ hyperthyroidism
    Niroshan Francis, Thanuya Francis, John H. Lazarus, Onyebuchi E Okosieme · 2020 · Expert Review of Endocrinology & Metabolism
47. Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves’ Ophthalmopathy Patients
    Ban Luo, Yuan Xu, Wei Wang · 2020 · Ocular Immunology and Inflammation
48. Thyroid Autoimmunity and Dysfunction in Sri Lankan Children and Adolescents After 22 Years of Sustained Universal Salt Iodization
    Renuka Jayatissa, Onyebuchi E Okosieme, Samantha Ranasinghe, Joanne L. Carter, Ishan P. Gunatunga, John H. Lazarus, Lakdasa D.K.E. Premawardhana · 2021 · Thyroid
49. Radioiodine therapy of Graves' disease
    Arnoldo Piccardo, Martina Ugolini, Vania Altrinetti · 2021 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
50. A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
    Richard C. Allen, Elizabeth A. Bradley, Robert G. Fante, Mark J. Lucarelli · 2021 · Ophthalmology
51. Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves’ disease
    Jwan A. Naser, Sorin V. Pislaru, Marius Nicolae Stan, Grace Lin · 2021 · Heart
52. Österreichischer Blutdruckkonsens 2019
    Österreichische Gesellschaft für Hypertensiologie, Thomas Weber, Österreichische Atherosklerosegesellschaft, Österreichische Diabetes Gesellschaft, Österreichische Gesellschaft für Internistische Angiologie, Österreichische Gesellschaft für Nephrologie, Österreichische Kardiologische Gesellschaft, Österreichische Gesellschaft für Neurologie, Österreichische Schlaganfall-Gesellschaft, Österr. Gesellschaft für Allgemeinmedizin et al. · 2019 · Wiener klinische Wochenschrift
53. Thyroid Emergencies: A Narrative Review
    Margaret Kruithoff, Benjamin J. Gigliotti · 2025 · Endocrine Practice
54. Combination of Molecular Adsorbent Recirculating System and Radioiodine for the Treatment of Concurrent Hyperthyroidism and Severe Liver Dysfunction: A Retrospective Cohort Study
    Qing Zhang, Yanxing Guan, Tianxin Xiang, Shaozheng Liu, Qingjie Chen, Qing Zhang · 2016 · Endocrine Practice
55. Serum tau levels are increased in patients with hyperthyroidism
    Lun-Xi Li, Tong Yang, Lu Guo, Da-Yan Wang, Chunhua Tang, Qiong Li, Haimei Yang, Jie Zhu, Lili Zhang · 2020 · Neuroscience Letters
56. Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis
    Vishal K. Patel, Lissa Padnick‐Silver, Sherwin D’Souza, Rajib Kumar Bhattacharya, Megan E. Francis-Sedlak, Robert J. Holt · 2021 · Endocrine Practice
57. Postoperative Complications After Total Thyroidectomy for Patients With Graves’ Disease
    Jennifer J. Liang, Rachel Irizarry, Lousette Saint Victor · 2022 · Otolaryngology
58. Screening and management of major endocrinopathies during pregnancy: an update
    Stavroula Α. Paschou, Evanthia Bletsa, Maria Papazisi, Nikoletta Mili, Fotini Kanouta, Georgia Kassi, Θεοδώρα Ψαλτοπούλου, Dimitrios G. Goulis, Irene V. Lambrinoudaki · 2022 · Endocrine
59. Could the Systemic Immune Inflammation Index Predict Diagnosis, Recovery Time, Hypothyroidism, and Recurrence Rates in Subacute Thyroiditis?
    Serpil Çiftel, Zeynep Tüzün · 2023 · International Journal of General Medicine
60. Correlation between gut microbiota and the development of Graves’ disease: A prospective study
    Yuanyuan Deng, Jiao Wang, Guijiao Xie · 2023 · iScience
61. Management of thyroid dysfunction and thyroid nodules in the ageing patient
    José Ignacio Martínez‐Montoro, Viyey Kishore Doulatram‐Gamgaram, Gabriel Olveira, Sergio Valdés, José Carlos Fernández‐García · 2023 · European Journal of Internal Medicine
62. Significance of HLA in Graves’ disease and Graves’ orbitopathy in Asian and Caucasian populations – a systematic review
    Magdalena Stasiak, Bartłomiej Stasiak, Katarzyna Zawadzka-Starczewska · 2023 · Frontiers in Immunology
63. Large method differences for free thyroid hormone assays in the hyperthyroid range can affect assessment of hyperthyroid status: Comparison of Abbott Alinity to Roche Cobas, Siemens Centaur and equilibrium dialysis LC-MS/MS
    Alexander B. Westbye, Finn Erik Aas, Sandra Rinne Dahl, Svetlana N. Zykova, Oskar Kelp, Louise Koren Dahll, Per Medbøe Thorsby · 2023 · Clinical Biochemistry
64. Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets
    Katarzyna Cieplińska, Emilia Niedziela, Aldona Kowalska · 2023 · Journal of Clinical Medicine
65. Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves’ hyperthyroidism: a randomized trial and a risk-scoring model
    Fereidoun Azizi, Atieh Amouzegar, Davood Khalili · 2024 · Endocrine
66. Perchlorates in the treatment of hyperthyroidism and thyrotoxicosis: a comprehensive review
    Giuseppe Lisco, Giacomo Accardo, Cinzia Pupilli, Pasqualino Malandrino, Vincenzo De Geronimo, Vincenzo Triggiani · 2024 · Endocrine
67. Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
    Sha Zhang, Yidong Wang, Zhan Qi · 2024 · International Journal of Clinical Pharmacy
68. Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study*
    Yuichiro Matsuo, Taisuke Jo, Hideaki Watanabe, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga · 2024 · Critical Care Medicine
69. Subclinical Hyperthyroidism and Cardiovascular Disease
    Hye Jeong Kim, Donald S.A. McLeod · 2024 · Thyroid
70. Thyroid and cardiovascular diseases
    SİNEM BAŞAK TAN ÖKSÜZ, Mustafa Şahi̇n · 2024 · TURKISH JOURNAL OF MEDICAL SCIENCES
71. Significance of Thyroid-Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves Disease
    Rongguang Peng, Pu Xie, Jin Zhou, Wenzhong Zhou, Yanqiu Wang, Xinxin Chen, Qinglei Yin, Liyun Shen, Lingyang Meng, Lei Ye et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
72. Analytical and Clinical Validation of Two Commercially Available Immunoassays Used in the Detection of TSHR Antibodies
    David J. Kemble, Tara Jackson, Mike Morrison, Mark A Cervinski, Robert D Nerenz · 2017 · The Journal of Applied Laboratory Medicine
73. Does Surgery Without Lugol’s Solution Pretreatment for Graves’ Disease Increase Surgical Morbidity?
    Frédéric Mercier, Mathieu Bonal, Florian Fanget, L. Maillard, Nathalie Laplace, Jean‐Louis Peix, Jean‐Christophe Lifante · 2018 · World Journal of Surgery
74. Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’ disease
    Xinxin Chen, Fengjiao Huang, Yicheng Qi, Mengxi Zhou, Qinglei Yin, Ying Hong Peng, Yulin Zhou, Guang Ning, Shu Wang · 2018 · Journal of Translational Medicine
75. Disease Presentation and Remission Rate in Graves Disease Treated With Antithyroid Drugs: is Gender Really A Factor?
    Talia Diker‐Cohen, Hadar Duskin‐Bitan, Ilan Shimon, Dania Hirsch, Amit Akirov, Gloria Tsvetov, Eyal Robenshtok · 2018 · Endocrine Practice
76. Cut off value of technetium uptake in the differential diagnosis of Graves, disease and subacute thyroiditis.
    Demir Fadime · 2020 · PubMed
77. Diagnosis and Management of Graves’ Disease in Thailand: A Survey of Current Practice
    Chutintorn Sriphrapradang · 2020 · Journal of Thyroid Research
78. Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease—Perspective of a European High‐Volume Center
    Kirsten Lindner, Jochen Kußmann, Volker Fendrich · 2020 · World Journal of Surgery
79. The role of laboratory medicine in the diagnosis of the hyperthyroidism
    Federica D’Aurizio · 2021 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
80. The Association of Thyroid Hormone Changes with Inflammatory Status and Prognosis in COVID-19
    Ceyda Dinçer Yazan, Can Ilgın, Onur Elbasan, Tuğçe Apaydın, Saida Dashdamirova, Tayfun Yigit, Uluhan Sili, Ayşegül Yağcı, Önder Şïrïkçï, Goncagül Haklar et al. · 2021 · International Journal of Endocrinology
81. Multi sensor application-based for measuring the quality of human urine on first-void urine
    Anton Yudhana, Subhas Chandra Mukhopadhyay, Oky Dicky Ardiansyah Prima · 2021 · Sensing and Bio-Sensing Research
82. Serum Selenium Levels in Patients with Graves Disease: Associations with Clinical Activity and Severity in a Retrospective Case-control Study
    Tae-Hwan Kim, JaeSang Ko, Bo Ram Kim, Dong Yeob Shin, Eun Jig Lee, Jin Sook Yoon · 2021 · Korean Journal of Ophthalmology
83. The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease
    Han-Sang Baek, Jaejun Lee, Chaiho Jeong, Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Min‐Hee Kim, Jae‐Hyoung Cho, Moo Il Kang, Dong‐Jun Lim · 2022 · Journal of the Endocrine Society
84. Evaluation of the diagnostic features and clinical course of COVID-19 vaccine–associated subacute thyroiditis
    Hayri Bostan, Serdar Kayıhan, Murat Çalapkulu · 2022 · HORMONES
85. Lipid profile abnormalities associated with endocrine disorders
    Ewelina Szczepanek‐Parulska, Jan Sokołowski, Dominika Dmowska, Jan Klimek, Tomasz Stasikowski, Paweł Zdebski, Michał Olejarz, Anna Gac, Michał Bartecki, Marek Ruchała · 2022 · Endokrynologia Polska
86. Perioperative management of the thyrotoxic patients: A systematic review
    Misganew Terefe Molla, Yosef Belay Bizuneh, Yonas Addisu Nigatu, Debas Yaregal Melesse · 2022 · Annals of Medicine and Surgery
87. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves’ disease and its relationship to the degree of hyperthyroidism
    Tianqi Liu, Xiuying Zhang, Long Li, Lingli Zhou, Jing Chen, Meng Li, Ying Gao, Xianghai Zhou, Xueyao Han, Linong Ji · 2022 · BMC Endocrine Disorders
88. Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis
    Hayri Bostan, Muhammed Erkam Sencar, Murat Çalapkulu, Serdar Kayıhan, Sema Hepşen, Aykut Çimşir, Umran Gul, İlknur Öztürk Ünsal, Özgür Özçelik, Muhammed Kızılgül et al. · 2022 · Endocrine
89. Image-guided Thermal Ablation as a Promising Approach to Both Nontoxic and Toxic Autonomously Functioning Thyroid Nodules
    Long Wang, Peiqing Wang, Zhijiang Chen · 2023 · Academic Radiology
90. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves’ disease, a pilot study
    Matrix Man Him Fung, Brian Hung‐Hin Lang · 2023 · European Radiology
91. Measuring Sweet and Bitter Taste in Children: Individual Variation due to Age and Taste Genetics
    Julie A. Mennella, Alissa A. Nolden, Nuala K. Bobowski · 2018 · Elsevier eBooks
92. Consideration of Occult Infection and Sepsis Mimics in the Sick Patient Without an Apparent Infectious Source
    Marina N. Boushra, Susan Ney Miller, Alex Koyfman, Brit Long · 2018 · Journal of Emergency Medicine
93. Normalization of thyroid function tests among thyrotoxicosis patients attending a University Hospital in North-West Ethiopia
    Eyob Alemayehu Gebreyohannes, Emneteab Mesfin Ayele, Soliana Alemayehu Tesfaye, Mohammed Assen Seid · 2019 · Thyroid Research
94. Therapeutic Plasma Exchange as a Bridge to Total Thyroidectomy in Patients with Severe Thyrotoxicosis
    Kelsey Tieken, Ameena Madan Paramasivan, Whitney Sears Goldner · 2019 · AACE Clinical Case Reports
95. Increasing Use of Thyroidectomy as Definitive Treatment for Hyperthyroidism
    Ammar A. Asban, Ashley Anue, Rongbing Xie, Herbert Chen · 2019 · Journal of Surgical Research
96. Thyroid Storm in a Toddler Presenting as a Febrile Seizure
    Jennifer M. Ladd, Bayane Sabsabi, Julia Elisabeth Von Oettingen · 2020 · PEDIATRICS
97. Usefulness of plasmapheresis in patients with severe complicated thyrotoxicosis
    Myrian Vinan-Vega, Bárbara Mantilla, Nusrat Jahan · 2020 · Baylor University Medical Center Proceedings
98. Associations of serum phthalate metabolites with thyroid hormones in GraMo cohort, Southern Spain
    Carolina Donat‐Vargas, Francisco M. Pérez-Carrascosa, Celia Gómez-Peña, Vicente Mustieles, Inmaculada Salcedo‐Bellido, Hanne Winther Frederiksen, Agneta Åkesson, Juan Pedro Arrebola · 2021 · Environmental Pollution
99. Thyroidectomy for Graves’ Disease Predicts Postoperative Neck Hematoma and Hypocalcemia: A North American cohort study
    Sadaf Mohtashami, Keith Richardson, Véronique‐Isabelle Forest · 2021 · Annals of Otology Rhinology & Laryngology
100. Thyroid-Stimulatory Antibody as a Predictive Factor for Graves’ Disease Relapse
     Tiago Santos, José Carlos Oliveira, Cláudia Freitas · 2022 · Cureus